Adoptive transfer of chimeric antigen receptor (CAR)-T cells specifically designed to target FAP-expressing cells has shown promise in depleting FAP+ populations, including CAFs, thus limiting tumor stroma formation and enhancing the effectiveness of chemotherapeutic agents (222–224). The gene discussed is FAP; the disease is neoplasm.